naltrexone has been researched along with Chronic Kidney Failure in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schairer, J; Thapa, SD | 1 |
Akai, M; Danda, Y; Gellert, R; Ide, K; Kawashima, Y; Ladefoged, SD; Mori, A; Ogasawara, M; Ueno, K; Ueno, Y; Wikström, B | 1 |
Alexander, AC; Dixon, R; Frye, RF; Johnston, J; Matzke, GR; Rault, RM; Reynolds, R | 1 |
Azar, R; Bah, S; Ballester, L; Brunet, C; Cazin, JC; Cazin, M; Dine, T; Gressier, B; Kambia, K; Luyckx, M; Odou, P | 1 |
1 review(s) available for naltrexone and Chronic Kidney Failure
Article | Year |
---|---|
Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Topics: Adult; Aged; Antipruritics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Naltrexone; Probability; Pruritus; Receptors, Opioid, kappa; Reference Values; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Uremia | 2005 |
1 trial(s) available for naltrexone and Chronic Kidney Failure
Article | Year |
---|---|
Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies.
Topics: Adult; Aged; Antipruritics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Naltrexone; Probability; Pruritus; Receptors, Opioid, kappa; Reference Values; Renal Dialysis; Risk Assessment; Severity of Illness Index; Treatment Outcome; Uremia | 2005 |
4 other study(ies) available for naltrexone and Chronic Kidney Failure
Article | Year |
---|---|
Narcotic-induced pain.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anorexia; Chronic Disease; Diabetes Mellitus, Type 1; Drug Administration Schedule; Endoscopy, Gastrointestinal; Gastroparesis; Humans; Hypertension; Kidney Failure, Chronic; Male; Naltrexone; Narcotic Antagonists; Nausea; Neuralgia; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2015 |
Nalmefene--a long-acting injectable opioid antagonist.
Topics: Clinical Trials as Topic; Costs and Cost Analysis; Dose-Response Relationship, Drug; Drug Overdose; Humans; Injections, Intravenous; Kidney Failure, Chronic; Liver Diseases; Naltrexone; Narcotic Antagonists; Postoperative Care; Respiratory Insufficiency | 1995 |
The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene.
Topics: Adult; Aged; Dose-Response Relationship, Drug; Female; Glucuronates; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Reference Values; Renal Dialysis | 1996 |
High-performance liquid chromatographic determination of naltrexone in plasma of hemodialysis patients.
Topics: Chromatography, High Pressure Liquid; Humans; Kidney Failure, Chronic; Naltrexone; Narcotic Antagonists; Pruritus; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity | 2000 |